Prabhudas Lilladhar
GSK has given an optimistic growth outlook on the back of 1) double digit Change in Estimates | Target | Reco HFD volume growth in 9MFY19 2) uptick in rural demand post consumption friendly budget 3) success of Horlicks Protein Plus in fast growth protein...
GlaxoSmithKline Pharmaceuticals Ltd.'s price crossed below 100Day SMA today
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended